List of insiders holdings for Emergent BioSolutions Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | El-Hibri Fuad Director |
2021-12-07 21:10:11 | 1,136,971 3,706,442 |
4,843,413 | Form 4 |
2 | Intervac L.L.C. 10% Owner |
2012-09-20 20:20:01 | 4,494,250 0 |
4,494,250 | Form 4 |
3 | Microscience Investments LTD Member of 13(d) group 10% Owner |
2007-03-16 14:18:24 | 3,636,801 0 |
3,636,801 | Form 13G |
4 | BIOPHARM L.L.C. 10% Owner |
2010-06-01 16:12:28 | 2,965,043 0 |
2,965,043 | Form 4 |
5 | PAPA JOSEPH C President and CEO |
2025-03-12 18:12:58 | 2,815,000 0 |
2,815,000 | Form 4 |
6 | Myers Robert Calvin Member 13(d) group owning >10% |
2007-02-14 12:43:52 | 2,394,045 0 |
2,394,045 | Form 13G |
7 | Biovac L.L.C. 13(d) group member, owns > 10% |
2007-02-14 12:30:52 | 1,599,155 0 |
1,599,155 | Form 13G |
8 | JP MORGAN PARTNERS BHCA LP JP MORGAN PARTNERS GLOBAL INVESTORS LP J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP J P MORGAN PARTNERS GLOBAL INVESTORS A LP J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN LLP JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN II L P JPMP MASTER FUND MANAGER L P JPMP GLOBAL INVESTORS L P JPMP CAPITAL CORP Member of 13(d) group |
2007-03-19 11:32:58 | 1,454,418 0 |
1,454,418 | Form 3 |
9 | Biologika L.L.C. Member 13(d) group owning >10% |
2008-06-06 18:11:33 | 1,399,764 0 |
1,399,764 | Form 4 |
10 | Michigan Biologic Products Inc. Member 13(d) group owning >10% |
2008-03-28 20:17:57 | 1,269,390 0 |
1,269,390 | Form 4 |
11 | Kramer Robert President and CEO |
2023-06-13 21:20:24 | 1,041,110 0 |
1,041,110 | Form 4 |
12 | ADVENT PRIVATE EQUITY FUND III A LTD PARTNERSHIP Member of 13(d) Group |
2007-06-29 17:08:51 | 925,537 0 |
925,537 | Form 13G |
13 | LINDAHL RICHARD S EVP, Chief Financial Officer |
2025-03-10 16:18:03 | 783,715 0 |
783,715 | Form 4 |
14 | Intervac Management L.L.C. 13(d) group member, owns > 10% |
2007-02-14 12:39:25 | 719,275 0 |
719,275 | Form 13G |
15 | ARPI L.L.C. 13(d) group member, owns > 10% |
2007-02-14 12:20:25 | 658,254 0 |
658,254 | Form 13G |
16 | Mulligan Seamus Director |
2019-03-21 16:18:12 | 56,141 545,590 |
601,731 | Form 4 |
17 | Merlin General Partner II LTD (as General Partner of the Merlin Biosciences Fund L.P.) Member of 13(d) group |
2007-03-12 19:21:48 | 498,722 0 |
498,722 | Form 3 |
18 | Havey Adam EVP, Business Operations |
2023-06-13 21:20:59 | 336,304 0 |
336,304 | Form 4 |
19 | Williams Paul Anthony SVP, Products Business |
2025-03-10 16:18:15 | 296,449 0 |
296,449 | Form 4 |
20 | ADVENT PRIVATE EQUITY FUND III B LTD PARTNERSHIP Member of 13(d) Group |
2007-03-12 19:58:34 | 229,497 0 |
229,497 | Form 3 |
21 | Lowry Simon C SVP, R&D, CMO |
2025-03-10 16:17:54 | 194,981 0 |
194,981 | Form 4 |
22 | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec |
2024-07-12 16:33:12 | 186,382 0 |
186,382 | Form 4 |
23 | Glessner Coleen EVP, Quality & Ethics, and CPL |
2025-04-09 18:35:50 | 176,176 0 |
176,176 | Form 4 |
24 | Perl Jessica SVP, General Counsel, Corp Sec |
2025-03-10 16:18:27 | 164,332 0 |
164,332 | Form 4 |
25 | Abdun-Nabi Daniel CEO |
2019-03-04 18:39:36 | 142,617 1,936 |
144,553 | Form 4 |
26 | SULLIVAN LOUIS W Director |
2024-05-28 21:14:55 | 130,443 0 |
130,443 | Form 4 |
27 | ADVENT PRIVATE EQUITY FUND III D LTD PARTNERSHIP Member if a 13(d) Group |
2007-03-12 20:00:49 | 125,921 0 |
125,921 | Form 3 |
28 | Arcuri Edward COO |
2007-05-10 11:04:35 | 115,083 0 |
115,083 | Form 4 |
29 | Harsanyi Zsolt Chairman |
2024-05-28 21:14:42 | 115,077 0 |
115,077 | Form 4 |
30 | DeGolyer Donald W Director |
2024-11-14 16:18:57 | 111,100 0 |
111,100 | Form 4 |
31 | Hartzel William SVP, Bioservices |
2025-04-09 18:36:02 | 109,122 0 |
109,122 | Form 4 |
32 | Fowler Neal Franklin Director |
2025-03-12 18:13:19 | 101,100 0 |
101,100 | Form 4 |
33 | Richard Ronald Director |
2024-05-28 21:14:17 | 96,862 0 |
96,862 | Form 4 |
34 | Dayal Sujata Tyagi Director |
2024-05-28 21:40:34 | 88,877 0 |
88,877 | Form 4 |
35 | SARAN ATUL EVP, Chief Strat & Dev Officer |
2023-03-02 14:43:12 | 86,645 0 |
86,645 | Form 4 |
36 | Katkin Keith Director |
2024-05-28 21:41:29 | 85,620 0 |
85,620 | Form 4 |
37 | ADVENT PRIVATE EQUITY FUND III C LTD PARTNERSHIP Member of 13(d) Group |
2007-03-12 19:59:49 | 64,018 0 |
64,018 | Form 3 |
38 | Strei Katherine EVP, Chief HR Officer |
2023-03-02 14:42:23 | 62,824 0 |
62,824 | Form 4 |
39 | Hauer Jerome M Director |
2023-05-30 19:08:39 | 57,508 0 |
57,508 | Form 4 |
40 | White Marvin L Director |
2024-11-13 16:04:50 | 54,092 0 |
54,092 | Form 4 |
41 | Zoon Kathryn C Director |
2025-03-12 18:13:08 | 44,482 0 |
44,482 | Form 4 |
42 | JOULWAN GEORGE A Director |
2022-05-31 16:20:57 | 40,244 0 |
40,244 | Form 4 |
43 | Keese Kyle EVP, BioSciences Division |
2011-03-17 15:31:43 | 39,954 0 |
39,954 | Form 4 |
44 | Elsey R Don Chief Financial Officer |
2012-03-16 15:06:13 | 38,914 0 |
38,914 | Form 4 |
45 | Emergent BioSolutions Inc. Sean Kirk, EVP, Manufacturing |
2019-06-03 21:13:43 | 36,624 0 |
36,624 | Form 3 |
46 | Niederhuber John Director |
2016-05-23 08:39:36 | 30,300 0 |
30,300 | Form 4/A |
47 | Merlin General Partner II LTD (as Managing Partner of the Merlin Biosciences Fund Gbr) Member of 13(d) group |
2007-03-12 19:19:19 | 29,972 0 |
29,972 | Form 3 |
48 | Chatfield Steven EVP, BioSciences |
2013-03-18 14:11:13 | 28,000 0 |
28,000 | Form 4 |
49 | Esposito Denise CLO |
2009-03-12 14:38:00 | 27,300 0 |
27,300 | Form 4 |
50 | Labinger Barry EVP, Biosciences Div. |
2015-11-17 17:15:40 | 25,182 0 |
25,182 | Form 4 |
51 | Bailey Sue Director |
2021-03-08 18:30:56 | 24,427 0 |
24,427 | Form 4 |
52 | ADVENT PRIVATE EQUITY FUND III GMBH & CO KG Member of 13(d) Group |
2007-03-12 20:08:22 | 18,118 0 |
18,118 | Form 3 |
53 | Kirk Sean EVP, Manufacturing & Tech Ops |
2021-04-01 18:54:16 | 17,776 0 |
17,776 | Form 4 |
54 | ADVENT PRIVATE EQUITY FUND III AFFILIATES Member of 13 (d) Group |
2007-03-12 20:01:49 | 15,098 0 |
15,098 | Form 3 |
55 | ALLBAUGH JOE M Director |
2008-05-23 10:13:49 | 14,400 0 |
14,400 | Form 4 |
56 | Malik Shahzad Director |
2007-06-18 19:15:12 | 14,400 0 |
14,400 | Form 4 |
57 | LOCKHART STEPHEN SVP Product Development |
2010-11-16 15:13:11 | 12,813 0 |
12,813 | Form 4 |
58 | Smith Karen L. EVP, Chief Medical Officer |
2021-05-11 16:30:11 | 11,888 0 |
11,888 | Form 4 |
59 | ADVENT MANAGEMENT III L P Member of 13(d) Group |
2007-03-12 20:07:21 | 4,530 0 |
4,530 | Form 3 |
60 | Zink Thomas SVP & CMO |
2007-05-21 15:41:58 | 1000 0 |
1000 | Form 4 |
61 | MILLER H HAYWOOD III Interim CEO |
2023-07-18 18:22:14 | 0 0 |
0 | Form 3 |
62 | Gibellini Mauro SVP, Corporate Dev. |
2007-06-06 15:10:32 | 0 0 |
0 | Form 4 |
63 | APAX EUROPE IV GP CO LTD Member of 13(d) group |
2008-10-17 11:12:09 | 0 0 |
0 | Form 13G |